Clinical Trial Results:
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chemotherapy in patients with metastatic breast cancer.
Summary
|
|
EudraCT number |
2005-000438-19 |
Trial protocol |
ES BE CZ DE IT |
Global completion date |
18 Apr 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Feb 2016
|
First version publication date |
21 Feb 2016
|
Other versions |
|
Summary report(s) |
2005-000438-19- Phase II - Oral vinorelbine in Breat cancer |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.